What: A randomized control trial presented at the Society of Maternal-Fetal Medicine found that postpartum women on nifedipine experienced just over 1% readmission compared to over 8% for those taking labetalol.
Key line: “Nifedipine should be the first-line agent for management of postpartum hypertension,” said researcher Lovgren, noting that even a 90% reduction in readmission rates could have a major impact on maternal mortality.
Source: Medscape
A study finds that higher white blood cell counts in postmenopausal women may signal severe COVID-19.
The Trump IVF Executive Order does not make IVF free but instead asks for policy recommendations to lower costs, marking an initial step.
One blood pressure medication outperformed another, potentially lowering postpartum readmission rates.
Cosmo UK explores the phenomenon dubbed ‘post‐birth control syndrome’ despite its unofficial status.
Research shows the causes of maternal mortality differ widely from state to state.
Beyond recreation, cannabis is being evaluated for therapeutic benefits in women’s care.
A new study suggests a blood test might help predict postpartum depression risk.
A study comparing sisters of women with and without pregnancy complications found that genetic and environmental factors may drive cardiovascular disease risk.
Cannabis producers are exploring new treatment areas in women’s health.
A small randomized‐control trial found semaglutide cut drinking by 40% in people with alcohol use disorder.
A study from the University of Washington finds significant racial and socioeconomic disparities in accessing same-day diagnostic services after an abnormal mammogram.
A study finds that postmenopausal women are significantly more at risk for long COVID compared to men.
An analysis of emerging investment trends shaping the future of women’s health research.
Cheryl Wishhover delivers a witty review of celebrity menopause products, questioning their true benefits and efficacy.
Women voice frustrations over intrusive social media ads during perimenopause.
KFF Health News reports a woman was billed over $14,000 for an IUD she thought was covered by insurance.
A study underscores that preventing preeclampsia is key to reducing serious postpartum complications.
The Cut’s Beauty Editor examines Botox resistance—a rare phenomenon where antibodies may reduce the effectiveness of neuromodulators like Botox.
RFK, Jr. is sworn in as HHS secretary and takes a dig at previous agency messaging while promising “the truth” so mothers can make informed decisions.
A federal judge temporarily halted Trump’s planned deep NIH funding cuts after attorneys general from 22 states sued to block the move.